Shots:

• Almirall will leverage Iktos’s generative modeling AI technology for compound optimization and accelerating the identification of drug candidates for its drug discovery program
• The collaboration will provide an opportunity to Almirall to combine its expertise with Iktos’ AI precision and celerity to improve QoL
• Iktos’ AI technology is based on deep generative models helps to bring speed & efficiency to the drug discovery process by designing virtual novel molecule having characteristics of novel drug candidates

Click here to­ read full press release/ article | Ref: Businesswire | Image: Iktos